Christian Gerdes

Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

Ekkehard Mössner, Peter Brünker, Samuel Moser et al. · Blood · 2010 · 957 citations · Full text

Life Sciences, Immunology, Oncology +17

European Society of Cardiology: Cardiovascular Disease Statistics 2017

Adam Timmis, Nick Townsend, Chris P Gale et al. · European Heart Journal · 2017 · 951 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 355 citations · Full text

Pharmacy, Immunology, Oncology +17

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 283 citations · Full text

Life Sciences, Immunology, Oncology +17

The intrinsic factor–vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein

Renata Kozyraki, John C. Fyfe, Mette Kristiansen et al. · Nature Medicine · 1999 · 271 citations

Life Sciences, Biochemistry, Cell Biology +12